Matrix 3D ultrasound-assisted thyroid nodule volume estimation and radiofrequency ablation: a phantom study

T Boers, S J Braak, M Versluis, S Manohar, T Boers, S J Braak, M Versluis, S Manohar

Abstract

Background: Two-dimensional (2D) ultrasound is well established for thyroid nodule assessment and treatment guidance. However, it is hampered by a limited field of view and observer variability that may lead to inaccurate nodule classification and treatment. To cope with these limitations, we investigated the use of real-time three-dimensional (3D) ultrasound to improve the accuracy of volume estimation and needle placement during radiofrequency ablation. We assess a new 3D matrix transducer for nodule volume estimation and image-guided radiofrequency ablation.

Methods: Thirty thyroid nodule phantoms with thermochromic dye underwent volume estimation and ablation guided by a 2D linear and 3D mechanically-swept array and a 3D matrix transducer.

Results: The 3D matrix nodule volume estimations had a lower median difference with the ground truth (0.4 mL) compared to the standard 2D approach (2.2 mL, p < 0.001) and mechanically swept 3D transducer (2.0 mL, p = 0.016). The 3D matrix-guided ablation resulted in a similar nodule ablation coverage when compared to 2D-guidance (76.7% versus 80.8%, p = 0.542). The 3D mechanically swept transducer performed worse (60.1%, p = 0.015). However, 3D matrix and 2D guidance ablations lead to a larger ablated volume outside the nodule than 3D mechanically swept (5.1 mL, 4.2 mL (p = 0.274), 0.5 mL (p < 0.001), respectively). The 3D matrix and mechanically swept approaches were faster with 80 and 72.5 s/mL ablated than 2D with 105.5 s/mL ablated.

Conclusions: The 3D matrix transducer estimates volumes more accurately and can facilitate accurate needle placement while reducing procedure time.

Keywords: Imaging (three-dimensional); Phantoms (imaging); Radiofrequency ablation; Thyroid nodule; Ultrasonography.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Method depictions. a Three-dimensional (3D) view of the phantom with nodule volume in milliliter (mL) being estimated. b Side view of the ablation set-up with a grounding pad, radiofrequency ablation needle, and transducer and the red triangle indicating the danger triangle. Beneath that the 3D matrix (real-time 3D transducer) view of a nodule ablation. c Slicing, photographing, and pixel-based analysis of the body and nodule after ablation. 2D: Two-dimensional (conventional 2D transducer); 3D: Three-dimensional; 3D matrix Real-time 3D transducer; 3Dms: 3D mechanically swept transducer;
Fig. 2
Fig. 2
Boxplot of the differences in mL of the volume estimation measurements as compared to the reference value per transducer and measurement approach with corresponding p values
Fig. 3
Fig. 3
Transversal (left) and sagittal (right) view of the nodule phantom during ablation with the three-dimensional (3D) matrix (real-time) transducer
Fig. 4
Fig. 4
Ablation results using conventional two-dimensional (2D) and three-dimensional mechanically swept (3Dms) transducer guidance. The blue triangle indicates the danger triangle, free from ablation in the nodule and outside the nodule. The magenta colour in the body indicates an overablation outside the nodule
Fig. 5
Fig. 5
Ablation results using 3D matrix guidance. The dashed line indicates the ablation needle orientation. The green circle indicates an area ablated closely to the edge with minimal ablation outside the target. The blue triangle indicates the danger triangle with zero ablation outside the target. The yellow circle indicates an edge of the nodule fully ablated as well as the area outside of the nodule showing ablation
Fig. 6
Fig. 6
Boxplot of the nodule ablation coverages per transducer with corresponding p values
Fig. 7
Fig. 7
Boxplot of the volume ablated outside the nodule per transducer with corresponding p values

References

    1. Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Investig. 2009;39:699–706. doi: 10.1111/j.1365-2362.2009.02162.x.
    1. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69:537–540. doi: 10.7326/0003-4819-69-3-537.
    1. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a Community: the Whickham Survey. Clin Endocrinol. 1977;7:481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x.
    1. Ridgway EC. Clinical review 30: Clinician’s evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab. 1992;74:231–235. doi: 10.1210/jcem.74.2.1730801.
    1. Kamran SC, Marqusee E, Kim MI et al (2013) Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab 98:564–570. 10.1210/jc.2012-2968
    1. De Ycaza AEE, Lowe KM, Dean DS, et al. Risk of malignancy in thyroid nodules with non-diagnostic fine-needle aspiration: a retrospective cohort study. Thyroid. 2016;26:1598–1604. doi: 10.1089/thy.2016.0096.
    1. Xu T, Wu Y, Wu RX et al (2019) Validation and comparison of three newly-released thyroid imaging reporting and data systems for cancer risk determination. Endocrine 64:299–307. 10.1007/s12020-018-1817-8
    1. Grani G, Lamartina L, Ascoli V et al (2018) Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: toward the “Right” TIRADS. J Clin Endocrinol Metab 104:95–102. 10.1210/jc.2018-01674
    1. Hegedüs L, Frasoldati A, Negro R, Papini E. European Thyroid Association Survey on Use of Minimally Invasive Techniques for Thyroid Nodules. Eur Thyroid J. 2020;9:194–204. doi: 10.1159/000506513.
    1. Cho SJ, Baek JH, Chung SR, Choi YJ, Lee JH. Long-term results of thermal ablation of benign thyroid nodules: a systematic review and meta-analysis. Endocrinol Metab. 2020;35:339–350. doi: 10.3803/EnM.2020.35.2.339.
    1. Trimboli P, Castellana M, Sconfienza LM et al (2020) Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine 67:35–43. 10.1007/s12020-019-02019-3
    1. Mauri G, Sconfienza LM. Percutaneous ablation holds the potential to substitute for surgery as first choice treatment for symptomatic benign thyroid nodules. Int J Hyperth. 2017;33:301–302. doi: 10.1080/02656736.2016.1257827.
    1. Papini E, Monpeyssen H, Frasoldati A, Hegedüs L. 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules. Eur Thyroid J. 2020;9:172–185. doi: 10.1159/000508484.
    1. Khanh HQ, Hung NQ, Vinh VH, Van Khoi N, Vuong NL. Efficacy of microwave ablation in the treatment of large (≥3 cm) benign thyroid nodules. World J Surg. 2020;44:2272–2279. doi: 10.1007/s00268-020-05432-2.
    1. Park VY, Han K, Seong YK et al (2019) Diagnosis of thyroid nodules: performance of a Deep learning convolutional neural network model vs. radiologists. Sci Rep 9:17843. 9:17843. 10.1038/s41598-019-54434-1
    1. Bernardi S, Dobrinja C, Fabris B et al (2014) Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol 2014:1–10. 10.1155/2014/934595
    1. Mauri G, Gennaro N, Lee MK, Baek JH. Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int J Hyperth. 2019;36:13–20. doi: 10.1080/02656736.2019.1622795.
    1. Sim JS, Baek JH. Long-term outcomes following thermal ablation of benign thyroid nodules as an alternative to surgery: the importance of controlling regrowth. Endocrinol Metab. 2019;34:117–123. doi: 10.3803/EnM.2019.34.2.117.
    1. Bernardi S, Giudici F, Cesareo R et al (2020) Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally invasive treatments of the thyroid group. Thyroid 30:1759–1770. 10.1089/thy.2020.0202
    1. Schlögl S, Werner E, Lassmann M et al (2001) The use of three-dimensional ultrasound for thyroid volumetry. Thyroid 11:569–574. 10.1089/105072501750302877
    1. Negussie AH, Partanen A, Mikhail AS et al (2016) Thermochromic tissue-mimicking phantom for optimisation of thermal tumour ablation. Int J Hyperth 32:239–243. 10.3109/02656736.2016.1145745
    1. Mikhail AS, Negussie AH, Graham C, Mathew M, Wood BJ, Partanen A. Evaluation of a tissue-mimicking thermochromic phantom for radiofrequency ablation. Med Phys. 2016;43:4304–4311. doi: 10.1118/1.4953394.
    1. Choi YJ, Baek JH, Hong MJ, Lee JH. Inter-observer variation in ultrasound measurement of the volume and diameter of thyroid nodules. Korean J Radiol. 2015;16:560–565. doi: 10.3348/kjr.2015.16.3.560.
    1. Andermann P, Schlögl S, Mäder U, Luster M, Lassmann M, Reiners C (2007) Intra- and interobserver variability of thyroid volume measurements in healthy adults by 2D versus 3D ultrasound. Nuklearmedizin 46:1–7. 10.1055/s-0037-1616621
    1. Özgen A, Erol C, Kaya A, et al. Interobserver and intraobserver variations in sonographic measurement of thyroid volume in children. Eur J Endocrinol. 1999;140:328–331. doi: 10.1530/eje.0.1400328.
    1. Baek J, Huh J, Kim M et al (2013) Accuracy of volume measurement using 3D ultrasound and development of CT-3D US image fusion algorithm for prostate cancer radiotherapy. Med Phys 40:021704. 10.1118/1.4767753
    1. Schiaffino S, Serpi F, Rossi D et al (2020) Reproducibility of ablated volume measurement is higher with contrast-enhanced ultrasound than with b-mode ultrasound after benign thyroid nodule radiofrequency ablation—a preliminary study. J Clin Med 9:1504. 10.3390/jcm9051504
    1. Chen J, You H, Li K. A review of thyroid gland segmentation and thyroid nodule segmentation methods for medical ultrasound images. Comput Methods Prog Biomed. 2020;185:105329. doi: 10.1016/j.cmpb.2020.105329.
    1. Reinhardt M, Brandmaier P, Seider D et al (2017) A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT). Contemp Clin Trials Commun 8:25–32. 10.1016/j.conctc.2017.08.004
    1. Turtulici G, Orlandi D, Corazza A et al (2014) Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med Biol 40:1447–1452. 10.1016/j.ultrasmedbio.2014.02.017
    1. Dobnig H, Amrein K. Value of monopolar and bipolar radiofrequency ablation for the treatment of benign thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2019;33:101283. doi: 10.1016/j.beem.2019.05.007.
    1. Culjat MO, Goldenberg D, Tewari P, Singh RS. A review of tissue substitutes for ultrasound imaging. Ultrasound Med Biol. 2010;36:861–873. doi: 10.1016/j.ultrasmedbio.2010.02.012.

Source: PubMed

3
Subscribe